IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (7)
ThinkEquity
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 | Inhibikase Ther | Health-Care | 10 | 1 | TEq | 249.7% | -1% | ||||
| Dec 17 | Virios Therapeu | Health-Care | 10 | 3 | TEq | 530.7% | 67.1% | ||||
| Nov 24 | Vision Marine T | Consumer-Services | 10 | 2 | TEq | 170.4% | 44.4% | ||||
| Oct 16 | Kiromic Biophar | Health-Care | 12 | 1 | TEq | 36.7% | -4.2% | ||||
| Aug 28 | Harbor Custom D | Basic-Industries | 6 | 1 | TEq | 105.9% | 25% | ||||
| Jul 31 | 1847 Goedeker I | Consumer-Durables | 9 | 1 | TEq | 76.7% | -1.1% | ||||
| Jan 29 | Annovis Bio Inc | Health-Care | 6 | 2 | TEq | 169.4% | 59.8% | ||||
*
Lead manager or one of top three managers in an underwriting team.